Updates in Obesity Management: A Focus on Pharmacotherapy in Clinical Practice

LIVEWEBINARDHPAMA

Add to Calendar Updates in Obesity Management: A Focus on Pharmacotherapy in Clinical Practice 1/26/2027 3:00:00 PM 1/27/2027 6:25:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?EID=4770 Description: Activity Code:API-02-P303This 2-day symposium aims to provide the healthcare professionals with up-to-date weight management strategies with a focus on obesity medications. This activity will include lectures as well as interactive sessions e.g. Q&A. It will be delivered in collaboration with speakers from local, regional and international institutions. Livestreamed via Zoom false MM/DD/YYYY


Date & Location
Tuesday, January 26, 2027, 3:00 PM - Wednesday, January 27, 2027, 6:25 PM, Livestreamed via Zoom

Overview

Activity Code: API-02-P303

This 2-day symposium aims to provide the healthcare professionals with up-to-date weight management strategies with a focus on obesity medications. This activity will include lectures as well as interactive sessions e.g. Q&A. It will be delivered in collaboration with speakers from local, regional and international institutions.


Target Audience
Specialties - Allied Health Professionals, Nurses, Pharmacists, Physicians, Researchers, Students

Overall Learning Objective
  1. Recognize the impact of obesity and weight loss on health
  2. Describe evidence-based strategies to manage obesity in special population
  3. Formulate an individualized patient-centered plan to manage patients before, during and after weight loss. 

Registration

  • Early bird rate (valid until December 27, 2026): QAR 190/USD 52

  • Regular rate (from December 28, 2025): QAR 250/USD 69

Registration closes ONE day before the activity. You will receive a separate join link for each day of the webinar on the day of the session.

Changes or Cancellations

1- Name changes or substitutions are not permitted.
2- All cancellation and refund requests must be made in writing and submitted via email to [email protected].
3- For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
4- We will attempt to process the refund within 30 days of receiving any cancellation request.
5- Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to  [email protected].


Accreditation


DHP 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 6.00 hours.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.


ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Tariq Chukir, MD, Deema Al-Sheikhly, MEHP, Phyllis Sui Muffuh Navti, DHSci, Hamza Rustom, RT, Hajer Hedfi, BSN 
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Director/ICR: Tariq Chukir, MD
Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty: Tariq Chukir, MD, Elamin Abdelgadir, MD, Sarah Barenbaum, MD, Dimpi Desai, MD, Michael Weintraub, MD
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing any unlabeled/unapproved use of drugs or products. 

Jaime Almandoz, MD, has disclosed the following financial relationships: 

  • Advisor-Novo Nordisk|Eli Lilly and Company|Boehringer Ingelheim|Abbvie|Pfizer|Amgen|Kailera|Rhythm|Rivus|Wave

Will not be discussing unlabeled/unapproved use of drugs or products.

Priya Jaisinghani, MD, has disclosed the following financial relationships:

  • Consulting Fee-BI|Lilly|Novo Nordisk|Madrigal

Will not be discussing unlabeled/unapproved use of drugs or products.

Robyn Pashby, PhD, has disclosed the following financial relationships:

  • Speakers Bureau-Kailera|Fractyl Health

  • Advisor-Viking Therapeutics

Will not be discussing unlabeled/unapproved use of drugs or products.

Sangeeta R Kashyap, MD, has disclosed the following financial relationships:

  • Grant or research support-Fractyl laboratories

  • Advisor-GI Dynamics Inc

Will not be discussing unlabeled/unapproved use of drugs or products.

Sonali Malhotra, MD, has disclosed the following financial relationships:

  • Employment-Astrazeneca

Will not be discussing unlabeled/unapproved use of drugs or products.

Tirissa Reid, MD, has disclosed the following financial relationships:

  • Honoraria-Chiesi|Acromegaly Community- lecturer|American College of Physicians|NEJM Group|American Diabetes Association

  • Speakers Bureau-Mediflix- medical education app

  • Membership on Advisory Committees or Review Panels, Board Membership, etc.-American Board of Obesity Medicine

  • Royalties or Patent Beneficiary-UpToDate

  • Grant or research support-CorMedix Defencath: Co-investigator

Will not be discussing unlabeled/unapproved use of drugs or products.

Raj Shah, MD, has disclosed the following financial relationships:

  • Honoraria-American Society of Gastrointesinal Endoscopy|The Endocrine Society|American Gastroenterological Association

  • Grant or research support-Endogenex

Will not be discussing unlabeled/unapproved use of drugs or products.

Elisabeth van Rossum, MD, has disclosed the following financial relationships:

  • Grant or research support-Dutch Ministry of Education, Culture and Science|Netherlands Organization of Scientific Research|Elisabeth Foundation|Rhythm Pharmaceuticals|European Union's Horizon Europe research and innovation programme

  • Royalties or Patent Beneficiary-Ambo Anthos publisher

  • Honoraria-Dutch Obesity Academy|Medische Scholing -in English: Medical Education|Medscape WebMD|Radcliffe CVRM|Bohn Stafleu van Loghum publisher|Prevents

  • Membership on Advisory Committees or Review Panels, Board Membership, etc.-Clinical lead obesity European Society of Endocrinology|Chair Partnership Overweight Netherlands|Chair committee National guideline on obesity in adults|Guideline Obesity Pharmacotherapy of the Endocrine Society

Will not be discussing unlabeled/unapproved use of drugs or products.

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated

Administrative Contact: Safia Rabia has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.

Will not be discussing unlabeled/unapproved use of drugs or products.


Additional Information

Recording, Transcription, and AI Tools

This educational activity is intended solely for registered participants. Except as expressly authorized by the organizers, participants may not record, photograph, reproduce, transcribe, summarize, distribute, or otherwise capture any portion of the activity, including through the use of artificial intelligence (AI) tools, automated notetaking applications, transcription services, or similar technologies.

Participants are expected to comply with all activity instructions and applicable institutional policies regarding recording and use of AI tools. The organizers reserve the right to take appropriate action in the event of unauthorized recording, transcription, or distribution of activity content including the removal of unauthorized AI bots or automated meeting assistants.

If an official recording is prepared by the organizers and made available to registered participants after the activity it will be for personal use only, and may not be shared, distributed, or further reproduced.

 

 Attendance and Credit Eligibility

 CE/CPD credit is awarded based on verified individual participation in the educational activity. Participants must register and join the activity under their own name and remain personally present for the duration required to receive credit.Where use of an AI bot, automated notetaking assistant, or similar tool has been expressly authorized, such authorization does not permit the tool to attend the activity in place of the registered participant. The presence of an automated tool does not, by itself, constitute attendance or participation by the registered participant for purposes of CE/CPD credit.

Where the organizers are unable to verify the registered participant’s attendance and participation in accordance with applicable CE/CPD requirements, credit will not be awarded.